Table III.

29 enriched significant pathways in the latent pathway identification analysis network.

Path ID	Description
hsa04512	Estraceelular matrix-receptor interaction
hsa04974	Protein digestion and absorption
hsa04060	Cytokine-cytokine receptor interaction
hsa05150	Staphylococcus aureus infection
hsa04610	Complement and coagulation cascades
hsa05146	Amoebiasis
hsa05323	Rheumatoid arthritis
hsa04380	Osteoclast differentiation
hsa04062	Chemokine signaling pathway
hsa04620	Toll-like receptor signaling pathway
hsa04145	Phagosome
hsa04640	Hematopoietic cell lineage
hsa04510	Focal adhesion
hsa04670	Leukocyte transendothelial migration
hsa05144	Malaria
hsa04350	Transforming growth factor-β signaling pathway
hsa05142	Chagas disease (American trypanosomiasis)
hsa04110	Cell cycle
hsa04971	Gastric acid secretion
hsa05412	Arrhythmogenic right ventricular cardiomyopathy
hsa04514	Cell adhesion molecules
hsa00564	Glycerophospholipid metabolism
hsa05414	Dilated cardiomyopathy
hsa00240	Pyrimidine metabolism
hsa05200	Pathways in cancer
hsa01100	Metabolic pathways
hsa04020	Calcium signaling pathway
hsa04010	Mitogen-activated protein kinase signaling pathway
hsa04080	Neuroactive ligand-receptor interaction